Journals / Turkish Journal of Obstetrics and Gynecology / 2017 / Cilt: 14 - Sayı: 3

Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?

Enflamatuvar belirteçleri kullanarak gebelik kolestazının ciddiyeti öngörülebilir mi?

Pages
160–165
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The use of inflammatory markers in the assessment of perinatal outcomes needs further studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP).Materials and Methods: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women.
📊
Key Findings & Data:Patients were categorized as mild ICP (<40 ?mol/L) and severe ICP (>=40 ?mol/L) with regard to serum bile acids.
💡
Conclusion & Impact:The use of inflammatory markers in the assessment of perinatal outcomes needs further studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP).Materials and Methods: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 ?mol/L) and severe ICP (>=40 ?mol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups.Results: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05). Conclusion: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies.

Özet

Amaç: Gebeliğin intrahepatik kolestazının (GİK) ciddiyeti ile enflamatuvar belirteçler arasındaki ilişkiyi incelemektir.Gereç ve Yöntemler: Bu retrospektif olgu-kontrol çalışması 84 GİK'li ve 145 yaş uyumlu sağlıklı gebe olan 229 gebe kadın üzerinde gerçekleştirilmiştir. Hastalar serum safra asit düzeylerine göre, hafif GİK ( =40 ?mol/L) olarak kategorize edilmiştir. Çalışmamızda bu iki grup arasında enflamatuvar belirteçler olan nötrofil-lenfosit oranı (NLO), platelet-lenfosit oranı (PLO), ortalama platelet hacmi (MPV) ve kırmızı kan hücreleri dağılım genişliği (RDW) karşılaştırılacaktır. Bulgular: GİK hastalarında RDW azalmış, beyaz kan hücresi (WBC), MPV, ve PLO artmıştır, ancak NLO'da önemli bir değişiklik izlenmemiştir. Hafif ve ciddi GİK grupları arasında karşılaştırma sonucunda NLO, PLO, WBC ve RDW benzer bulunmakla beraber MPV seviyesi ciddi grupta anlamlı olarak yüksek tespit edilmiştir (p<0,05).Sonuç: GİK hastalarında WBC, MPV, PLO anlamlı olarak artan, RDW ise anlamlı olarak azalan enflamatuvar belirteçlerdir. MPV ise hastalığın ciddiyeti ile birlikte artış gösteren bir belirteçtir. GİK hastalarında bu enflamatuvar belirteçlerin perinatal sonuçlarla ilişkisini incelemek için ise daha fazla çalışmaya ihtiyaç vardır.

🔖

Cite This Article

ABİDE, Ç. Y., VURAL, F., KILIÇÇI, Ç., ERGEN, E. B., YENİDEDE, İ., ESER, A., PEKİN, O. (2017). Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?. Turkish Journal of Obstetrics and Gynecology, Cilt: 14 - Sayı: 3, 160–165. https://ajindex.com/articles/376309

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33:1012-21
  2. Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol 2006;5:202-5
  3. Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am 2010;37:269-82
  4. Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999;94:189-93
  5. Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH. Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. BJOG 2001;108:1190-2
  6. Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006;43:723- 8
  7. Geenes V, Williamson C. Liver disease in pregnancy. Best Pract Res Clin Obstet Gynecol 2015;29:612-24
  8. Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015;212:100.e1-e7
  9. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049-66
  10. Diken Z, Usta IM, Nassar AH. A Clinical Approach to Intrahepatic Cholestasis of Pregnancy. Am J Perinatol 2014;31:1-8
  11. Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based casecontrol study. Hepatology 2014;59:1482-91
  12. Rook M, Vargas J, Caughey A, Bacchetti P, Rosenthal P, Bull L. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort. PLoS One 2012;7:e28343
  13. Asulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am j obstet Gynecol 1996;175:9957- 60
  14. Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S. Predicting fetal aspyhxia in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstet 2009;280:975-9
  15. Nunez J, Nunez E, Bodi V, Sanchis J, Minana G, Mainar L, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting longterm mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008;101: